Clostridium perfringens ß toxoid,types B, C and D: ≥ 10 IU*; Clostridium perfringens ε toxoid,types B, C and D: ≥ 5 IU*; Clostridium noyvi α toxoid, type B: ≥ 3.5 IU*; Clostridium septicum α toxoid: ≥ 2.5 IU*; Anaculture of Clostridium chauvoei:100% protection**. Clostridium sordelli toxoid:100% protection**. Adjuvant.
*International Units (of antitoxin per ml of serum).
**Level of protection in guinea pigs (as per Ph.Eur.).
Adult Sheep and Goats: To prevent enterotoxaemia (pulpy kidney disease), sudden death, blackleg and necrotic hepatitis.
Lambs and Kids: To prevent dysentery, haemorrhagic enteritis, pulpy kidney disease and blackleg.
Cattle: To prevent enterotoxaemia, sudden death, blackleg, black disease and necrotic hepatitis.
A sporadic anaphylactic reaction may appear in some sensitive animals. In such a case administer an antihistaminic.
Administer the vaccine at a room temperature between +15 and +25 ºC.
Shake before and during administration.
Sheep and Goats: 2 ml/adult animal; and 1 ml/young animal.
Cattle: 4 ml/animal.
Generally, the following vaccination programme is recommended: First vaccination: Vaccinate and revaccinate within an interval of 20 to 25 days. Booster vaccination: Administer one dose every 12 months. In areas where pulpy kidney disease is prevalent, vaccinate every 6 months (spring and autumn).
Lambs and kids can be vaccinated a few days after birth.
Store at +2 to +8 ºC, avoiding freezing.
250 ml bottle.
Under veterinary prescription
The information contained in this page is purely informative and is in no way to be taken as strict prescription guidelines. This information may vary from one country to another based on local legislations. To know the exact and valid prescription information for your area contact the HIPRA office nearest you.